Avinger Inc (AVGR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Avinger Inc (AVGR) has a cash flow conversion efficiency ratio of -0.738x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.86 Million) by net assets ($3.88 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Avinger Inc (AVGR) total market value for the company's overall valuation and market capitalisation.
Avinger Inc - Cash Flow Conversion Efficiency Trend (2012–2023)
This chart illustrates how Avinger Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Avinger Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avinger Inc ranked by their cash flow conversion efficiency. See cash flow to debt ratio of Avinger Inc to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Blaize Holdings, Inc. Warrants
NASDAQ:BZAIW
|
-0.507x |
|
Ortin Global Limited
NSE:ORTINGLOBE
|
-0.627x |
|
CME Group Bhd
KLSE:7018
|
-0.047x |
|
Im Cannabis Corp
NASDAQ:IMCC
|
-1.169x |
|
BELGRAVIA HARTFORD CAP.
F:ECA
|
1.398x |
|
Mantex AB
ST:MANTEX
|
-1.685x |
|
INCUVO S.A. ZY -50
F:68X
|
0.135x |
|
Akanda Corp
NASDAQ:AKAN
|
0.530x |
Annual Cash Flow Conversion Efficiency for Avinger Inc (2012–2023)
The table below shows the annual cash flow conversion efficiency of Avinger Inc from 2012 to 2023. View Avinger Inc (AVGR) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $-6.20 Million | $-14.43 Million | 2.327x | +157.56% |
| 2022-12-31 | $4.15 Million | $-16.76 Million | -4.042x | -150.40% |
| 2021-12-31 | $9.72 Million | $-15.70 Million | -1.614x | -42.30% |
| 2020-12-31 | $13.08 Million | $-14.84 Million | -1.135x | +54.69% |
| 2019-12-31 | $6.89 Million | $-17.26 Million | -2.504x | -28.27% |
| 2018-12-31 | $9.46 Million | $-18.47 Million | -1.952x | -302.07% |
| 2017-12-31 | $-35.69 Million | $-34.48 Million | 0.966x | +107.72% |
| 2016-12-31 | $4.24 Million | $-53.07 Million | -12.513x | -377.14% |
| 2015-12-31 | $15.59 Million | $-40.88 Million | -2.623x | -1830.66% |
| 2014-12-31 | $-143.87 Million | $-21.80 Million | 0.152x | -57.96% |
| 2013-12-31 | $-112.78 Million | $-40.66 Million | 0.360x | -24.66% |
| 2012-12-31 | $-73.64 Million | $-35.23 Million | 0.478x | -- |
About Avinger Inc
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to prov… Read more